Chlorpheniramine/methscopolamine/phenylephrine Pregnancy and Breast Feeding Warnings
Chlorpheniramine/methscopolamine/phenylephrine is also known as: Aerohist Plus, Aerokid, AH-Chew, AH-Chew II, Ah-chew Ultra, Ah-Chew Ultra Tannate, Allergy DN PE, AlleRx PE Dose Pack, Chlor-Mes, Chlor-Mes D, CPM-PE-MSC, DA Chewable, DA II, Dallergy, Dallergy ER, Dallergy PE, Dallergy Syrup, Dehistine, Denaze, DriHist SR, Drize, Drysec, Dura Tan PE, Dura-Vent/DA, Duradryl, Duradryl JR, Duradryl SR, Durahist PE, DuraTan PE, Duravent, Duravent-DA, Ex-Histine, Extendryl Chews, Extendryl JR, Extendryl Seniors, Extendryl SR, Hista-Vent DA, Histatab PH, Liqui-Allergy, Nohist PE, Nohist Plus, Nohist Plus Jr, Norel SD, Omnihist II LA, Omnihist L.A., Omnihist LA, PCM, PCM Allergy, Prehist D, QV-Allergy, Ralix, Re-Drylex Jr, Redur-PCM, RelCof DN PE, RelCof PE, Rescon, Rescon MX, Scopohist, ScopoHist-PE, Sinodec, SymPak PDX, Triall, WE Allergy
Overview
It is not known if Chlorpheniramine/Methscopolamine/Phenylephrine Suspension can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Chlorpheniramine/Methscopolamine/Phenylephrine Suspension while you are pregnant. It is not known if Chlorpheniramine/Methscopolamine/Phenylephrine Suspension is found in breast milk. Do not breast-feed while taking Chlorpheniramine/Methscopolamine/Phenylephrine Suspension.
Chlorpheniramine/methscopolamine/phenylephrine Pregnancy Warnings
Chlorpheniramine/methscopolamine/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/methscopolamine/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
The Collaborative Perinatal Project monitored 1,070 first trimester exposures and 3,931 exposures which occurred anytime during pregnancy. No evidence was found to suggest a relationship to large categories of malformations. Antihistamine exposure in the first trimester in general was not associated with an increased risk of malformations.
Chlorpheniramine/methscopolamine/phenylephrine Lactation Warnings
There are no data on the excretion of chlorpheniramine/methscopolamine/phenylephrine into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
